NL-OMON21034
Recruiting
Not Applicable
Radiation dose intensity study in breast cancer in young women: a randomized phase III trial of additional dose to the tumor bed.
Prof. dr H. Bartelink, AvL/NKI, Plesmanlaan 121, 1069 CX Amsterdam0 sites1,160 target enrollmentTBD
ConditionsBreast cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast cancer
- Sponsor
- Prof. dr H. Bartelink, AvL/NKI, Plesmanlaan 121, 1069 CX Amsterdam
- Enrollment
- 1160
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age 50 years or younger;
- •2\. Histological diagnosis of invasive mammary cancer including all subtypes of
- •invasive adenocarcinoma;
Exclusion Criteria
- •1\. Residual microcalcifications on mammogram;
- •2\. All histological types of malignancies other than invasive adenocarcinoma;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Radiation dose intensity study in breast cancer in young women: a randomised phase III trial of additional dose to the tumour bedBreast cancerCancerISRCTN45066831Commission for Clinical Applied Research (Commissie voor Klinisch Toegepast Onderzoek [CKTO]) (The Netherlands)1,160
Active, not recruiting
Not Applicable
Prone Breast Radiotherapy Treatment Planning Observational StudyBreast Cancer FemaleNCT02237469Vincent Vinh-Hung280
Completed
Phase 3
Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.Breast CancerNCT00156806AHS Cancer Control Alberta231
Active, not recruiting
Phase 3
Radiation Dose Intensity Study in Breast Cancer in Young WomenBreast CancerNCT00212121The Netherlands Cancer Institute2,400
Active, not recruiting
Not Applicable
Accelerated Partial Breast Irradiation StudyBreast Cancer FemaleNCT03437395Sentara Norfolk General Hospital139